GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AlzeCure Pharma AB (FRA:AC6) » Definitions » SpecialCharges

AlzeCure Pharma AB (FRA:AC6) SpecialCharges


View and export this data going back to 2019. Start your Free Trial

What is AlzeCure Pharma AB SpecialCharges?

Special Charges only applies to banks.


AlzeCure Pharma AB Business Description

Traded in Other Exchanges
Address
Halsovagen 7, Huddinge, SWE, SE 141 57
AlzeCure Pharma AB is a Swedish pharmaceutical company engaged in drug research with a primary focus on Alzheimer's disease. The company develops several drugs within its three research platforms NeuroRestore, Alzstatin, and Painless. The company's drug candidates include; ACD440, which is in the clinical development phase for the treatment of neuropathic pain, ACD856, ACD857, ACD679, and ACD680 for the treatment of Alzheimer's disease, and ACD137 for the treatments of severe pain in conditions such as osteoarthritis.